Literature DB >> 12904131

Safety of fluoroquinolones in paediatrics.

Laura Cuzzolin1, Vassilios Fanos.   

Abstract

In the last few years, there has been increasing pressure to use fluoroquinolones in paediatric patients, since these antibiotics offer the advantage of an oral treatment regimen on an out-patient basis. However, even although this class of antibiotics generally remains well-tolerated, the restriction of fluoroquinolone use in children on a compassionate basis, which derives from their potential to cause cartilage toxicity, limits the safety data in this population and suggests a cautious use. This review reports the data of the literature on the safety of fluoroquinolones in different districts, focusing on the side effects in children and drug interactions. Moreover, data available in the literature with regards to side effects in children are reported, with particular attention to their potential in arthropathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12904131     DOI: 10.1517/14740338.1.4.319

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  3 in total

Review 1.  Antimicrobial therapy in childhood asthma and wheezing.

Authors:  Arne Simon; Oliver Schildgen
Journal:  Treat Respir Med       Date:  2006

2.  Systemic quinolones and risk of retinal detachment III: a nested case-control study using a US electronic health records database.

Authors:  Mohamed Kadry Taher; James A G Crispo; Yannick Fortin; Ryan Moog; Douglas McNair; Lise M Bjerre; Franco Momoli; Donald Mattison; Daniel Krewski
Journal:  Eur J Clin Pharmacol       Date:  2022-03-15       Impact factor: 3.064

3.  Systemic quinolones and risk of acute liver failure I: Analysis of data from the US FDA adverse event reporting system.

Authors:  Mohamed Kadry Taher; Abdallah Alami; Christopher A Gravel; Derek Tsui; Lise M Bjerre; Franco Momoli; Donald R Mattison; Daniel Krewski
Journal:  JGH Open       Date:  2021-06-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.